GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korean Drug Co Ltd (XKRX:014570) » Definitions » EBITDA Margin %

Korean Drug Co (XKRX:014570) EBITDA Margin % : -9.97% (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Korean Drug Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Korean Drug Co's EBITDA for the three months ended in Dec. 2024 was ₩-1,766 Mil. Korean Drug Co's Revenue for the three months ended in Dec. 2024 was ₩17,704 Mil. Therefore, Korean Drug Co's EBITDA margin for the quarter that ended in Dec. 2024 was -9.97%.


Korean Drug Co EBITDA Margin % Historical Data

The historical data trend for Korean Drug Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korean Drug Co EBITDA Margin % Chart

Korean Drug Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.87 17.18 20.09 12.31 9.68

Korean Drug Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.29 23.09 3.20 22.14 -9.97

Competitive Comparison of Korean Drug Co's EBITDA Margin %

For the Drug Manufacturers - General subindustry, Korean Drug Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Korean Drug Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Korean Drug Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Korean Drug Co's EBITDA Margin % falls into.


;
;

Korean Drug Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Korean Drug Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=7066.607/73001.424
=9.68 %

Korean Drug Co's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-1765.85/17704.058
=-9.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Korean Drug Co  (XKRX:014570) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Korean Drug Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Korean Drug Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Korean Drug Co Business Description

Traded in Other Exchanges
N/A
Address
486 Sukwang-ri Sindun-myun, Icheon, Gyeonggi, KOR, 457-840
Korean Drug Co Ltd is engaged in manufacturing and marketing of pharmaceutical products in South Korea. Its products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food.

Korean Drug Co Headlines

No Headlines